Texas 2013 - 83rd Regular

Texas House Bill HB3262 Latest Draft

Bill / House Committee Report Version Filed 02/01/2025

Download
.pdf .doc .html
                            83R24982 PMO-D
 By: Miller of Comal H.B. No. 3262
 Substitute the following for H.B. No. 3262:
 By:  Sheffield of Coryell C.S.H.B. No. 3262


 A BILL TO BE ENTITLED
 AN ACT
 relating to pharmacy benefit managers contracting with the child
 health plan program, the Medicaid managed care program, and health
 plans for certain government employees.
 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
 SECTION 1.  Chapter 531, Government Code, is amended by
 adding Subchapter Y to read as follows:
 SUBCHAPTER Y. PHARMACY BENEFIT MANAGERS
 Sec. 531.990.  APPLICABILITY. This subchapter applies only
 to a Medicaid managed care program under Chapter 533 and the child
 health plan program.
 Sec. 531.991.  TRANSPARENCY IN PHARMACY BENEFIT MANAGEMENT.
 (a) In this section, "maximum allowable cost" means a maximum
 reimbursement amount for a group of therapeutically and
 pharmaceutically equivalent multiple source medications.
 (b)  Each contract to provide pharmacy benefit manager
 services must require the pharmacy benefit manager to:
 (1)  establish:
 (A)  a method of calculating, updating, and
 revising a maximum allowable cost for each covered medication;
 (B)  intervals not to exceed seven days for
 updating or revising the maximum allowable cost for each medication
 on the maximum allowable cost list; and
 (C)  for that contract a single maximum allowable
 cost list that uniformly serves as a basis for the calculation of
 reimbursement amounts for pharmacy claims covered by the child
 health plan program or Medicaid managed care program;
 (2)  develop and maintain a public Internet website and
 post and maintain on the website the information required by
 Subdivision (1)(C);
 (3)  notify each retail pharmacy affected by a
 modification of a maximum allowable cost of the modification on the
 date of the modification;
 (4)  disclose the data sources from which the pharmacy
 benefit manager obtains pricing data used in establishing a maximum
 allowable cost; and
 (5)  not less frequently than once a week, notify each
 retail pharmacy affected by the pharmacy benefit manager's
 substitution or deletion of, or addition to, a data source from
 which the pharmacy benefit manager obtains pricing data used in
 establishing a maximum allowable cost of the substitution,
 deletion, or addition.
 (c)  A contract to provide pharmacy benefit manager services
 must require the pharmacy benefit manager to provide to the
 commission the information described by Subsections (b)(1)(B) and
 (C). On request, the commission shall provide the information to a
 pharmacist or pharmacy.
 (d)  A contract to provide pharmacy benefit manager services
 must require that each medication on a maximum allowable cost list:
 (1)  is listed as "A" or "B" rated in the most recent
 version of the United States Food and Drug Administration's Drug
 Products with Therapeutic Equivalence Evaluations, also known as
 the Orange Book;
 (2)  is rated "NR" or "NA" by Medi-Span; or
 (3)  has a similar rating by a nationally recognized
 reference.
 (e)  A contract to provide pharmacy benefit manager services
 must require the pharmacy benefit manager to:
 (1)  provide a procedure for a retail pharmacy to
 challenge a listed maximum allowable cost;
 (2)  respond to a challenge under that procedure not
 later than the 15th day after the date the challenge is made;
 (3)  if the challenge is successful, adjust the maximum
 allowable cost effective on the date the challenge is resolved and
 apply the adjustment to all retail pharmacies under the contract;
 (4)  if the challenge is denied, provide each reason
 for the denial; and
 (5)  report every 90 days to the commission the total
 number of challenges made and denied in the preceding 90-day period
 to the maximum allowable cost for each medication the maximum
 allowable cost of which was challenged during that period.
 SECTION 2.  Subchapter B, Chapter 1551, Insurance Code, is
 amended by adding Section 1551.0671 to read as follows:
 Sec. 1551.0671.  TRANSPARENCY IN PHARMACY BENEFIT
 MANAGEMENT. (a) In this section, "maximum allowable cost" means a
 maximum reimbursement amount for a group of therapeutically and
 pharmaceutically equivalent multiple source medications.
 (b)  Each contract to provide pharmacy benefit manager
 services must require the pharmacy benefit manager to:
 (1)  establish:
 (A)  a method of calculating, updating, and
 revising a maximum allowable cost for each covered medication;
 (B)  intervals not to exceed seven days for
 updating or revising the maximum allowable cost for each medication
 on the maximum allowable cost list; and
 (C)  for that contract a single maximum allowable
 cost list that uniformly serves as a basis for the calculation of
 reimbursement amounts for pharmacy claims covered by the group
 benefits program;
 (2)  develop and maintain a public Internet website and
 post and maintain on the website the information required by
 Subdivision (1)(C);
 (3)  notify each retail pharmacy affected by a
 modification of a maximum allowable cost of the modification on the
 date of the modification;
 (4)  disclose the data sources from which the pharmacy
 benefit manager obtains pricing data used in establishing a maximum
 allowable cost; and
 (5)  not less frequently than once a week, notify each
 retail pharmacy affected by the pharmacy benefit manager's
 substitution or deletion of, or addition to, a data source from
 which the pharmacy benefit manager obtains pricing data used in
 establishing a maximum allowable cost of the substitution,
 deletion, or addition.
 (c)  A contract to provide pharmacy benefit manager services
 must require the pharmacy benefit manager to provide to the board of
 trustees the information described by Subsections (b)(1)(B) and
 (C). On request, the board of trustees shall provide the
 information to a pharmacist or pharmacy.
 (d)  A contract to provide pharmacy benefit manager services
 must require that each medication on a maximum allowable cost list:
 (1)  is listed as "A" or "B" rated in the most recent
 version of the United States Food and Drug Administration's Drug
 Products with Therapeutic Equivalence Evaluations, also known as
 the Orange Book;
 (2)  is rated "NR" or "NA" by Medi-Span; or
 (3)  has a similar rating by a nationally recognized
 reference.
 (e)  A contract to provide pharmacy benefit manager services
 must require the pharmacy benefit manager to:
 (1)  provide a procedure for a retail pharmacy to
 challenge a listed maximum allowable cost;
 (2)  respond to a challenge under that procedure not
 later than the 15th day after the date the challenge is made;
 (3)  if the challenge is successful, adjust the maximum
 allowable cost effective on the date the challenge is resolved and
 apply the adjustment to all retail pharmacies under the contract;
 (4)  if the challenge is denied, provide each reason
 for the denial; and
 (5)  report every 90 days to the board of trustees the
 total number of challenges made and denied in the preceding 90-day
 period to the maximum allowable cost for each medication the
 maximum allowable cost of which was challenged during that period.
 SECTION 3.  Subchapter C, Chapter 1575, Insurance Code, is
 amended by adding Section 1575.111 to read as follows:
 Sec. 1575.111.  TRANSPARENCY IN PHARMACY BENEFIT
 MANAGEMENT. (a) In this section, "maximum allowable cost" means a
 maximum reimbursement amount for a group of therapeutically and
 pharmaceutically equivalent multiple source medications.
 (b)  Each contract to provide pharmacy benefit manager
 services must require the pharmacy benefit manager to:
 (1)  establish:
 (A)  a method of calculating, updating, and
 revising a maximum allowable cost for each covered medication;
 (B)  intervals not to exceed seven days for
 updating or revising the maximum allowable cost for each medication
 on the maximum allowable cost list; and
 (C)  for that contract a single maximum allowable
 cost list that uniformly serves as a basis for the calculation of
 reimbursement amounts for pharmacy claims covered by the group
 program;
 (2)  develop and maintain a public Internet website and
 post and maintain on the website the information required by
 Subdivision (1)(C);
 (3)  notify each retail pharmacy affected by a
 modification of a maximum allowable cost of the modification on the
 date of the modification;
 (4)  disclose the data sources from which the pharmacy
 benefit manager obtains pricing data used in establishing a maximum
 allowable cost; and
 (5)  not less frequently than once a week, notify each
 retail pharmacy affected by the pharmacy benefit manager's
 substitution or deletion of, or addition to, a data source from
 which the pharmacy benefit manager obtains pricing data used in
 establishing a maximum allowable cost of the substitution,
 deletion, or addition.
 (c)  A contract to provide pharmacy benefit manager services
 must require the pharmacy benefit manager to provide to the trustee
 the information described by Subsections (b)(1)(B) and (C). On
 request, the trustee shall provide the information to a pharmacist
 or pharmacy.
 (d)  A contract to provide pharmacy benefit manager services
 must require that each medication on a maximum allowable cost list:
 (1)  is listed as "A" or "B" rated in the most recent
 version of the United States Food and Drug Administration's Drug
 Products with Therapeutic Equivalence Evaluations, also known as
 the Orange Book;
 (2)  is rated "NR" or "NA" by Medi-Span; or
 (3)  has a similar rating by a nationally recognized
 reference.
 (e)  A contract to provide pharmacy benefit manager services
 must require the pharmacy benefit manager to:
 (1)  provide a procedure for a retail pharmacy to
 challenge a listed maximum allowable cost;
 (2)  respond to a challenge under that procedure not
 later than the 15th day after the date the challenge is made;
 (3)  if the challenge is successful, adjust the maximum
 allowable cost effective on the date the challenge is resolved and
 apply the adjustment to all retail pharmacies under the contract;
 (4)  if the challenge is denied, provide each reason
 for the denial; and
 (5)  report every 90 days to the trustee the total
 number of challenges made and denied in the preceding 90-day period
 to the maximum allowable cost for each medication the maximum
 allowable cost of which was challenged during that period.
 SECTION 4.  Subchapter B, Chapter 1579, Insurance Code, is
 amended by adding Section 1579.058 to read as follows:
 Sec. 1579.058.  TRANSPARENCY IN PHARMACY BENEFIT
 MANAGEMENT. (a) In this section, "maximum allowable cost" means a
 maximum reimbursement amount for a group of therapeutically and
 pharmaceutically equivalent multiple source medications.
 (b)  Each contract to provide pharmacy benefit manager
 services must require the pharmacy benefit manager to:
 (1)  establish:
 (A)  a method of calculating, updating, and
 revising a maximum allowable cost for each covered medication;
 (B)  intervals not to exceed seven days for
 updating or revising the maximum allowable cost for each medication
 on the maximum allowable cost list; and
 (C)  for that contract a single maximum allowable
 cost list that uniformly serves as a basis for the calculation of
 reimbursement amounts for pharmacy claims covered by a health
 coverage plan;
 (2)  develop and maintain a public Internet website and
 post and maintain on the website the information required by
 Subdivision (1)(C);
 (3)  notify each retail pharmacy affected by a
 modification of a maximum allowable cost of the modification on the
 date of the modification;
 (4)  disclose the data sources from which the pharmacy
 benefit manager obtains pricing data used in establishing a maximum
 allowable cost; and
 (5)  not less frequently than once a week, notify each
 retail pharmacy affected by the pharmacy benefit manager's
 substitution or deletion of, or addition to, a data source from
 which the pharmacy benefit manager obtains pricing data used in
 establishing a maximum allowable cost of the substitution,
 deletion, or addition.
 (c)  A contract to provide pharmacy benefit manager services
 must require the pharmacy benefit manager to provide to the trustee
 the information described by Subsections (b)(1)(B) and (C). On
 request, the trustee shall provide the information to a pharmacist
 or pharmacy.
 (d)  A contract to provide pharmacy benefit manager services
 must require that each medication on a maximum allowable cost list:
 (1)  is listed as "A" or "B" rated in the most recent
 version of the United States Food and Drug Administration's Drug
 Products with Therapeutic Equivalence Evaluations, also known as
 the Orange Book;
 (2)  is rated "NR" or "NA" by Medi-Span; or
 (3)  has a similar rating by a nationally recognized
 reference.
 (e)  A contract to provide pharmacy benefit manager services
 must require the pharmacy benefit manager to:
 (1)  provide a procedure for a retail pharmacy to
 challenge a listed maximum allowable cost;
 (2)  respond to a challenge under that procedure not
 later than the 15th day after the date the challenge is made;
 (3)  if the challenge is successful, adjust the maximum
 allowable cost effective on the date the challenge is resolved and
 apply the adjustment to all retail pharmacies under the contract;
 (4)  if the challenge is denied, provide each reason
 for the denial; and
 (5)  report every 90 days to the trustee the total
 number of challenges made and denied in the preceding 90-day period
 to the maximum allowable cost for each medication the maximum
 allowable cost of which was challenged during that period.
 SECTION 5.  Subchapter B, Chapter 1601, Insurance Code, is
 amended by adding Section 1601.065 to read as follows:
 Sec. 1601.065.  TRANSPARENCY IN PHARMACY BENEFIT
 MANAGEMENT. (a) In this section, "maximum allowable cost" means a
 maximum reimbursement amount for a group of therapeutically and
 pharmaceutically equivalent multiple source medications.
 (b)  Each contract to provide pharmacy benefit manager
 services must require the pharmacy benefit manager to:
 (1)  establish:
 (A)  a method of calculating, updating, and
 revising a maximum allowable cost for each covered medication;
 (B)  intervals not to exceed seven days for
 updating or revising the maximum allowable cost for each medication
 on the maximum allowable cost list; and
 (C)  for that contract a single maximum allowable
 cost list that uniformly serves as a basis for the calculation of
 reimbursement amounts for pharmacy claims covered by the basic
 coverage;
 (2)  develop and maintain a public Internet website and
 post and maintain on the website the information required by
 Subdivision (1)(C);
 (3)  notify each retail pharmacy affected by a
 modification of a maximum allowable cost of the modification on the
 date of the modification;
 (4)  disclose the data sources from which the pharmacy
 benefit manager obtains pricing data used in establishing a maximum
 allowable cost; and
 (5)  not less frequently than once a week, notify each
 retail pharmacy affected by the pharmacy benefit manager's
 substitution or deletion of, or addition to, a data source from
 which the pharmacy benefit manager obtains pricing data used in
 establishing a maximum allowable cost of the substitution,
 deletion, or addition.
 (c)  A contract to provide pharmacy benefit manager services
 must require the pharmacy benefit manager to provide to the
 governing board of the system the information described by
 Subsections (b)(1)(B) and (C). On request, the system shall
 provide the information to a pharmacist or pharmacy.
 (d)  A contract to provide pharmacy benefit manager services
 must require that each medication on a maximum allowable cost list:
 (1)  is listed as "A" or "B" rated in the most recent
 version of the United States Food and Drug Administration's Drug
 Products with Therapeutic Equivalence Evaluations, also known as
 the Orange Book;
 (2)  is rated "NR" or "NA" by Medi-Span; or
 (3)  has a similar rating by a nationally recognized
 reference.
 (e)  A contract to provide pharmacy benefit manager services
 must require the pharmacy benefit manager to:
 (1)  provide a procedure for a retail pharmacy to
 challenge a listed maximum allowable cost;
 (2)  respond to a challenge under that procedure not
 later than the 15th day after the date the challenge is made;
 (3)  if the challenge is successful, adjust the maximum
 allowable cost effective on the date the challenge is resolved and
 apply the adjustment to all retail pharmacies under the contract;
 (4)  if the challenge is denied, provide each reason
 for the denial; and
 (5)  report every 90 days to the system the total number
 of challenges made and denied in the preceding 90-day period to the
 maximum allowable cost for each medication the maximum allowable
 cost of which was challenged during that period.
 SECTION 6.  Subchapter Y, Chapter 531, Government Code, and
 Sections 1551.0671, 1575.111, 1579.058, and 1601.065, Insurance
 Code, as added by this Act, apply only to a contract with a pharmacy
 benefit manager entered into or renewed on or after the effective
 date of this Act.
 SECTION 7.  This Act takes effect September 1, 2013.